Results 131 to 140 of about 44,008 (229)

Synergistic inhibition of macular vascular permeability in diabetic edema: Ginsenoside Rg3 enhances ranibizumab efficacy by targeting angiopoietin‐like protein 4 and vascular endothelial growth factor via neuropilin/RhoA signaling

Journal of Diabetes Investigation, Volume 17, Issue 5, Page 751-765, May 2026.
Molecular mechanism of synergistic antagonism of ANGPTL4 and VEGF by ginsenoside Rg3 combined with ranibizumab, regulating the NRP/RhoA pathway to inhibit macular edema. ABSTRACT Aims This study investigated the molecular mechanisms by which ginsenoside Rg3 combined with ranibizumab alleviates diabetic macular edema (DME), focusing on antagonizing ...
Jiexin Yu, Xingyu Li, Yanli Liu
wiley   +1 more source

Diabetic Macular Edema

Asia-Pacific Journal of Ophthalmology, 2020
openaire   +2 more sources

Relationship between Macular Thickness and the Ratio of Vascular Endothelial Growth Factor to Its Soluble Receptor 1 in Non-Proliferative Diabetic Retinopathy

مجله دانشکده پزشکی اصفهان, 2012
Background: The goal of this study was to determine the ratio of vascular endothelial growth factor (VEGF) to soluble VEGF receptor 1 (SVEGFR1) in aqueous humor of patients with non-proliferative diabetic retinopathy (NPDR).
Zahra Hasanpour, Shaghayegh Haghjooy Javanmard, Zahra Abbaspoor, Gholam Ali Naderian, Mehdi Jahanmard   +4 more
doaj  

Visual improvement after long-term success of pancreatic transplantation [PDF]

, 1990
Andreas G. Tzakis, Black, Friberg, Patricia B. Carroll, Ramsey, Thomas E. Starzl, Thomas R. Friberg   +6 more
core   +1 more source

Diabetic Macular Edema

Diabetic macular edema (DME) is defined as the buildup of fluid within the retina in the extracellular space, specifically at the level of the macula in the inner nuclear, outer plexiform, Henle’s fiber layer, and subretinal space. Diabetes mellitus is one of the leading causes of visual impairment in industrialized countries and DME is the main reason
Emily D. Cole, Eduardo A. Novais, Nadia K. Waheed   +2 more
openaire   +2 more sources

Primary treatment of diabetic macular edema

Clinical Interventions in Aging, 2009
Tushar M Ranchod, Stuart L FineScheie Eye Institute, Department, of Ophthalmology, University of Pennsylvania, Philadelphia, PA, USAAbstract: Diabetic macular edema (DME) is a leading cause of vision loss in older Americans.
Tushar M Ranchod, Stuart L Fine
doaj  

Management of diabetic macular edema: from anti-VEGF to emerging therapies. [PDF]

Front Med (Lausanne)
Ji M, Wei W, Gong H, Zhang G.
europepmc   +1 more source

Effects of anti-VEGF therapy on choroidal thickness in eyes with diabetic macular edema. [PDF]

BMC Ophthalmol
Shi XN, Zhang QY, Ju CJ, Xu YC, Xiong ZH.   +4 more
europepmc   +1 more source

Cost-effectiveness analysis of the use of faricimab in diabetic macular edema in China. [PDF]

J Comp Eff Res
Shi F, Tan S, Shu Y, Liu T, Xia Y, Buehrer C, Han S.   +6 more
europepmc   +1 more source

Biomarkers of Diabetic Macular Edema on Optical Coherence Tomography After Cataract Surgery. [PDF]

J Vitreoretin Dis
Tran T, Goh J, Rogers S, Qureshi S, Lim LL.   +4 more
europepmc   +1 more source